Nurse-Administered Propofol Versus Midazolam and Meperidine for Upper Endoscopy in Cirrhotic Patients

American Journal of Gastroenterology

Volumn 98, Issue 11, 2003, Pages 2440-2447

  Weston, Brian R ^a   Chadalawada, Vidyasree ^a   Chalasani, Naga ^a   Kwo, Paul ^a   Overley, Christine A ^a   Symms, Michelle ^a   Strahl, Eloise ^a   Rex, Douglas K ^a,b  

^a INDIANA UNIVERSITY MEDICAL CENTER   (United States)

^b University Hospital 4100   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIDAZOLAM; PETHIDINE; PROPOFOL;

ABDOMINAL PAIN; ADULT; ALERTNESS; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; ARTICLE; BOLUS INJECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL ENDOSCOPY; HEADACHE; HUMAN; INJECTION PAIN; LIVER CIRRHOSIS; MALE; NAUSEA; NURSE; OUTCOMES RESEARCH; PATIENT MONITORING; PATIENT SATISFACTION; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECOVERY ROOM; SCREENING TEST; SEDATION; SIDE EFFECT; VERTIGO; VOMITING;

EID: 0344496205     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.08668.x     Document Type: Article

References (51)

1. McGuire BM. Safety of endoscopy in patients with end stage liver disease. Gastrointest Endosc Clin North Am 2001;11:111-30.
2. Zaman A, Becker T, Lapidus J, et al. Risk factors for the presence of varices in cirrohotic patients without a history of variceal hemomorhage. Arch Intern Med 2001;161:2564-70.
3. Pascal J-P, Cales P, Multicenter Study Group. Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices. N Engl J Med 1987;317:856-61.
4. Daneshmend TK, Bell GD, Logan RF. Sedation for upper gastrointestinal endoscopy: Results of a nationwide survey. Gut 1991;31:12-5.
5. Keefe EB, O'Connor KW. ASGE survey of endoscopic sedation and monitoring practices. Gastrointest Endosc 1990;36: S13-8.
6. Keefe EB. Sedation and analgesia for endoscopy. Gastroenterology 1995;108:932-4.
7. Froehlich F, Schwizer W, Thorens J, et al. Conscious sedation for gastroscopy: Patient tolerance and cardiorespiratory parameters. Gastroenterology 1995;108:697-704.
8. Benjamin SB. Complications of conscious sedation. Gastrointest Endosc Clin North Am 1996;6:277-86.
9. Macgilchrist AJ, Birnie RP, Cook A, et al. Pharmacokinetics and pharmacodynamics of intravenous midazolam in patients with severe alcohol cirrhosis. Gut 1986;27:190-5.
10. Assy N, Rosser BG, Grahame GR, et al. Risk of sedation for upper GI endsocopy exacerbating subclinical hepatic encephalopathy. Gastrointest Endosc 1999;49:690-4.
11. nd ed. Baltimore: Williams & Wilkins, 1988:85-111.
12. Arrowsmith JB, Gesterman BB, Fleischer DE, et al. Results from the American Society for Gastrointestinal Endoscopy US Food and Drug Administration collaborative study on complication rates and drug use during gastrointestinal endoscopy. Gastrointest Endosc 1991;37:421-7.
13. American Society for Gastrointestinal Endoscopy (ASGE Standard of Practice Committee). Sedation and monitoring of patients undergoing gastrointestinal endoscopic procedures. Gastrointest Endosc 1995;42:626-9.
14. American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-anesthesiologists. Practice guidelines for sedation and analgesia by non-anesthesiologists. Anesthesiology 2002:96:1004-17.
15. Diab FH, Kinf PD, Barthel JS, et al. Efficacy and safety of combined meperidine and midazolam for EGD sedation compared with midazolam alone. Am J Gastroenterol 1996;91:1120-5.
16. Tegeder I, Lotsch J, Geisslinger G. Pharmacokinetics of opioids in liver disease. Clin Pharmacokinet 1999;37:17-40.
17. Dundee JW, Halliday NJ, Harper KW, et al. Midazolam, a review of its pharmacological and therapeutic use. Drugs 1984;28:519-43.
18. Smith MT, Eadie MJ, Brophy TOR. The pharmacokinetics of midazolam in man. Eur J Clin Pharmacol 1981;19:271-8.
19. Pentikainen PJ, Valisalmi L, Himberg J, et al. Pharmacokinetics of midazolam following intravenous and oral administration in patients with cirrhotic liver disease and in healthy subjects. J Clin Pharmacol 1989;29:272-7.
20. Klotz U, McHorse TS, Wilkinson GR, et al. The effect of cirrhosis on the disposition and elimination of meperidine in man. Clin Pharmacol Ther 1974;16:667-75.
21. Pond SM, Tong T, Benowitz NL, et al. Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects. Clin Pharmacol Ther 1981;30:183-8.
22. Rinetti M, Ascalone V, Colombi ZL, et al. A pharmacokinetic study of midazolam in compensated liver cirrhosis. Int J Clin Pharmacol Res 1985;6:405-11.
23. Gitlin N, Lewis DC, Hinkley L. The diagnosis and prevalence of subclinical encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis. J Hepatol 1986;3:75-82.
24. Newcomer MK, Brozer SR. Complications of upper gastrointestinal endoscopy and their management. Gastrointest Endosc Clin North Am 1994;4:551-70.
25. Nelson DB, Barkun AN, Block KP, et al. Propofol use during gastrointestinal endoscopy. Gastrointest Endosc 2001;53:876-9.
26. Graber RG. Propofol in the endoscopy suite: An anesthesiologist's perspective. Gastrointest Endosc 1999;49:803-6.
27. Bryson HM, Fulton SR, Faulds D. Propofol, an update of its use in anesthesia and conscious sedation. Drugs 1995;50:513-59.
28. Dubois A, Balatoni E, Peeters JP, et al. Use of propofol for sedation during gastrointestinal endoscopies. Anaesthesia 1998;43(suppl):75-80.
29. Koshy G, Nair S, Norkus EP, et al. Propofol versus midazolam and meperidine for conscious sedation in GI endoscopy. Am J Gastroenterol 2000;95:1476-9.
30. Carlsson U, Grattidge P. Sedation for upper gastrointestinal endoscopy: A comparative study of propofol and midazolam. Endoscopy 1995;27:240-3.
31. Rex DK, Overley C, Kinser K, et al. Safety of propofol administered by registered nurses with gastroenterologist supervision in 2000 endoscopic cases. Am J Gastroenterol 2002;97:1159-63.
32. Sipe B, Rex DK, Latinovich D, et al. Propofol versus midazolam/ meperidine for outpatient colonoscopy: Administration by nurses supervised by endoscopists. Gastrointest Endosc 2002;55:815-25.
33. Vargo JJ, Zuccaro G, Dumot JA, et al. Gastroenterologist-administered propofol versus meperidine and midazolam for advanced upper endoscopy; a prospective randomized trial. Gastroenterology 2002;123:8-16.
34. Patterson KW, Casey PB, Murray JB, et al. Propofol sedation for outpatient upper gastrointestinal endoscopy: A comparison with midazolam. Br J Anaesth 1991;67:108-11.
35. Wehrmann T, Kokabpick S, Lembcke B, et al. Efficacy and safety of intravenous propofol sedation during ERCP: A prospective, controlled study. Gastrointest Endosc 1999;49:677-83.
36. Schnider TW, Minto CF, Shafer SL, et al. The influence of age on propofol pharmacodynamics. Anesthesiology 1999;90:1502-16.
37. Kazama T, Takeuchi K, Kazuyuki I, et al. Optimal propofol plasma concentration in young, middle-aged, and elderly patients. Anesthesiology 2000;93:662-9.
38. Servin F, Cockshott ID, Farinotti R, et al. Propofol pharmacokinetics in patients with cirrhosis. Br J Anaesth 1999;65:177-83.
39. Owens WD, Felts JA, Spitznagel EL. ASA physical status classifications: A study of consistency of ratings. Anesthesiology 1978;49:239-43.
40. Keats AS. The ASA classification of physical status: A recapitulation. Anesthesiology 1978;49:233.
41. Abrams GA, Fallon MB, Nail C, et al. Pulse oximetry: Utility in detecting arterial hypoxemia in subjects with cirrhosis. Hepatology 1999;30: 435A (abstract).
42. Freeman ML. Sedation and monitoring for gastrointestinal endoscopy. Gastrointest Endosc Clin North Am 1994;4:475-99.
43. Chernik DA, Gillings D, Laine H, et al. Validity and reliability of the Observer's Assessment of Alertness/Sedation Scale: Study with intravenous sedation. J Clin Psychopharmacol 1990;10:244-51.
44. Darwin P, Zangara J, Heller T, et al. Unsedated esophagoscopy for the diagnosis of esophageal varices in patients with cirrhosis. Endoscopy 2000;32:971-3.
45. Mosca S, Balzano A. Is routine topical anesthesia or conscious sedation necessary in upper endoscopy, especially in patients with liver cirrhosis? Endoscopy 2001;33:639-40.
46. Gilberstaldt SJ, Gilberstaldt H, Zieve L, et al. Psychomotor defects in cirrhotic patients without overt encephalopathy. Arch Intern Med 1980;140:519-20.
47. Vargo JJ, Zuccaro G, Dumot JA, et al. Gastroenterology-administered propofol for therapeutic upper endoscopy with graphic assessment of respiratory activity: A case series. Gastrointest Endosc 2000;52:250-5.
48. Vargo JJ, Zuccaro G, Dumot JA, et al. Automated graphic assessment of respiratory activity is superior to pulse oximetry and visual assessment for the detection of early respiratory depression during therapeutic upper endoscopy. Gastrointest Endosc 2002;55:826-31.
49. Bell GD. Premedication, preparation, and surveillance. Endoscopy 2002;34:2-12.
50. Bower AL, Ripepi A, Deilger J, et al. Bispectral index monitoring of sedation during endoscopy. Gastrointest Endosc 2000;52:192-6.
51. Johansen JW, Sebel PS. Development and clinical application of electroencephalographic bispectrum monitoring. Anesthesiology 2000;93:1336-44.